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Abstract
Radiosensitive neurogenic stem cells reside in the hippocampi, suggesting that avoidance of the
hippocampi may be an important strategy to reduce potential radiation-related cognitive effects. Six
patients treated for base of skull tumours were re-planned using co-planar helical fan beam arc therapy
(tomotherapy) and co-planar and non-coplanar volumetric arc techniques (RapidArc). The hippocampi
were contoured as avoidance structures with the specific goal of minimising the dose. Two gross target
volume (GTV) to planning target volume (PTV) expansions (10 and 2 mm) were considered to evaluate the
impact of margin selection on organ at risk (OAR) sparing. The dose prescription was 50 Gy to >95% of
the PTV. Comparison of the hippocampus avoidance plans demonstrated the importance of non-coplanar
delivery when the 10 mm margin was used. With the 2 mm margin, both co-planar and non-coplanar
delivery provided similar degrees of sparing. A mean dose of 34 Gy and a V6Gy <5% to the hippocampi
was realised with the hippocampus sparing techniques. Our comparisons suggest interventions to mini-
mise GTV to PTV margins will have a more profound influence on multiple OAR sparing than the choice of
intensity modulated arc delivery technique.
Keywords
Hippocampus; intensity modulated radiotherapy; brain tumour
INTRODUCTION
Late radiation toxicity of the central nervous
system (CNS) tissue generally becomes evident
6 months or later after irradiation. These side
effects are generally irreversible and progressive,
and may manifest as focal brain injury or
cognitive impairment. Specifically, memory
impairment and neurocognitive dysfunction
can be treatment-related morbidities which
are particularly problematic in patients with
extended survival.1 Patients with benign base
of brain tumours, such as meningioma and pitu-
itary adenoma, tend to have high rates of local
control after radiation. Given the associated
long survival, these patients are at risk for
neurocognitive late effects.24 The typical
growth pattern of these tumours is expansile
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and minimally invasive, providing an opport-
unity to minimise late side effects through
advanced radiotherapy delivery techniques5
that avoid critical structures and minimise the
volume of brain irradiated.
Radiation injury of the brain is mediated by
many different pathways including small vessel
injury, inflammatory effects and demyelina-
tion. The effect of radiation on neurogenic
stem cells is also a possible contributor to
late cognitive effects. Specifically, radiation-
induced impairment of neurogenesis in the
subventricular zone of the lateral ventricles
and the subgranular zone of the dentate gyrus
of the hippocampus has been identified as a
potential mediator of late effects contributing
to neurocognitive dysfunction.6 Recognition
that neurogenesis occurs in the hippocampus
of adult humans7 suggests that radiation injury
to this structure could have significant implica-
tions for neurocognitive function. Similar to
other populations of stem cells, neural stem
cells in the hippocampus are highly sensitive
to radiation.6,8
Advanced radiation planning techniques have
been proposed to decrease the neurocognitive
morbidity by decreasing dose to the medial
temporal lobe where the hippocampi are
located.811 Focal radiotherapy for base of skull
lesions with proximity of the medial temporal
lobes to base of skull structures also puts the
hippocampi at risk and they are particularly sub-
jected to moderately high radiation doses in tra-
ditional two- or three-field techniques that
incorporate lateral beam arrangements.12 The
conformal avoidance properties of helical
tomotherapy (HT) have been previously
demonstrated to provide a favourable balance
of planning target volume (PTV) coverage,
conformal dose, and organ at risk sparing com-
pared to other radiotherapy techniques for base
of skull tumours using non-hippocampus spar-
ing techniques.13 Our primary goals with this
comparative study were to (i) identify the mag-
nitude of hippocampus sparing that might be
achievable with various intensity-modulated
arc techniques and PTVs, and (ii) delineate the
importance of non-coplanar versus coplanar
techniques to realise this benefit.
MATERIALS AND METHODS
Six patients with base of brain tumours (four
pituitary adenoma, two meningioma of the
parasellar region) previously treated at the
London Regional Cancer Program were
selected for this planning study. All patients
had been previously scanned using a helical
CT scanner (Philips 5000) with 3 mm slice
thickness from the vertex of the skull to the
bottom of the second thoracic vertebral body.
Hippocampus contours were defined with
reference to previous protocols for delineating
hippocampus volumes on MRI14 and input
from an experienced neuro-radiologist (A.L.).
A set of anatomic boundaries was developed
to delineate the hippocampus on axial CT
images. The anterior boundary was defined by
the most anterior aspect of the temporal horn.
The lateral boundary was the medial wall of
the temporal horn. The medial margin was the
cerebral spinal fluid in the uncal and ambient
cisterns. The posterior extent was defined by a
line between the atrium of the lateral ventricle
and the colliculi. Superiorly, the hippocampi
were contoured to the level of the superior col-
liculi. The inferior boundary was at the level of
the interpeduncular cistern and dorsum sella.
The hippocampi were contoured by the same
individual (E.W.), based on CT data and, where
available (two sets), were cross-referenced with
MRI data.
Organs at risk (OARs) were otherwise deli-
neated as for the initial treatment plan. Avoid-
ance structures contoured include lens, eyes,
optic nerves, cerebrum, cerebellum, and brain-
stem. Maximum OAR doses were defined as:
brain, brain stem, optic chiasm, and optic
nerves: 50 Gy; eye (whole): 20 Gy; lens with
3 mm margin: 7 Gy. PTVs using margins of
10 mm (PTV10) and 2 mm (PTV2) were
defined based on the previously delineated gross
tumour [gross target volume (GTV)] used for
clinical treatment. The 10 mm
margin included a 5 mm clinical target
volume (CTV) expansion and an additional
5 mm PTV expansion which reflects current
uncertainty in target volume delineation on
CT and immobilisation with our mask-based
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immobilisation. The PTV2 scenario was
explored to approximate the degree of hippo-
campus sparing that might be achieved with
the use of multi-modality target volume delin-
eation and image guidance technologies. In all
plans, the prescription dose for this study was
50 Gy in 25 fractions, with 95% of the PTV
to receive at least 50 Gy.
Tomotherapy treatment planning
CT datasets and structures were transferred to
the tomotherapy planning workstation (Tomo
Therapy Inc., Madison, Wisconsin) using
the DICOM RT protocol. The tomotherapy
station re-sampled the CT datasets in 256 ·
256 voxels with slice thickness re-sampled to
the smallest slice separation in the original
CT data-set. The planning system used an
inverse treatment planning process based on
iterative least squares minimisation of an
objective function.15 A superposition/convo-
lution algorithm was used to calculate the
dose. The optimisation was guided using pre-
cedence, importance, and penalty factor para-
meters for CNS as previously described,16
with the addition of the hippocampus as an
avoidance structure. HT optimisation para-
meters included fan field width of 2.5 cm,
pitch of 0.215, and a modulation factor of
3.0. Tomotherapy plans were generated for
PTV10 and PTV2 options that sought to
achieve maximum hippocampus sparing while
maintaining PTV coverage and irradiation to
other OAR at or below the defined tolerance
limits.
Volumetric arc treatment planning
RapidArc uses continuous variation of the
instantaneous dose rate, MLC leaf positions,
and gantry rotational speed to optimise the
dose distribution. Details of the RapidArc
optimisation process have been published pre-
viously by our group.17,18 To minimise the
contribution of tongue and groove effect dur-
ing the arc rotation, as well as to benefit from
leaf trajectories non-coplanar with respect to
patient’s axis, the collimator rotation in Rapi-
dArc remains fixed to a non-zero value. In
the present study, the collimator was rotated
to 40. For the volumetric arc treatment plan-
ning, three plans for each of PTV10 and PTV2
were generated: rapid arc (RA)_1, a single
coplanar arc 360 long; RA_2, one coplanar
arc (360) and one orthogonal arc of 180
from (180 to 0) with couch angles of 0
and 90, respectively; RA_3, one coplanar arc
360 long and two non-coplanar arcs 210
long from 180 to 30 with couch angles of
0, 45 and þ45, respectively. As for the
HT plans, the RA plans were designed for
maximum hippocampus sparing while main-
taining PTV coverage and while keeping other
OAR doses at or below the defined tolerance
limits.
Plan comparison metrics
For PTV coverage, DVH parameters of D99,
D95, and D1 were used for comparison pur-
poses. D99 and D1 were used as substitutes for
minimum and maximum dose, respectively, to
avoid erroneous comparison of dose per voxel
metrics for different calculation grids in HT
and RA treatment planning systems. For brain
(PTV excluded), D5, D20, and D50; and for
brainstem, D1, D10, and D50 were the primary
metrics for comparison. Relevant clinical para-
meters remain speculative for hippocampi com-
parisons. For sparing directed at the stem cell
population which is quite radiosensitive, vol-
ume based parameters reflecting dose to the
entire structure (i.e., mean dose) are important
and this was therefore included as a comparison
metric. Recognising the exquisite radiosensitiv-
ity of stem cell populations, Gutie´rrez et al. set
objectives of keeping the dose to the entire hip-
pocampi less than 6 Gy.11 Other authors have
noted a threshold for neurocognitive side effects
and MRI changes when doses exceed 1820
Gy.19 Thus dose metrics of D5, D20, D50,
V6Gy, and V18Gy to both unilateral hippo-
campi and as a paired structure were analyzed.
We also examined metrics for OARs includ-
ing eyes and optic nerves. Cumulative
dosevolume histograms for the six patients
for the GTV, PTV and OAR were calculated.
Differences in dosevolume outcomes of the
treatment planning parameters were assessed
for significance using paired, two-sided t-tests
with significance of the p value set at <0.01 to
adjust for multiple comparisons.
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RESULTS
An illustration of a non-hippocampus sparing
versus hippocampus sparing HT plan for a
patient with a pituitary tumour is illustrated in
Figure 1. In delineating the hippocampus as
avoidance structures for our series of six patients,
the total hippocampus volumes contoured ran-
ged from 8.52 to 11.23 cm3, in comparison to
literature values of total hippocampus volumes
of 4.99 cm3 (ref. 11) to 5.66 cm3 (ref. 20). Our
volumes may have been somewhat larger due
to the lower resolution of the hippocampus on
CT imaging required a contouring approach
delineated by anatomical boundaries with greater
inherent margin than MRI-based planning.
A comparison among the hippocampus spar-
ing techniques including target volume cover-
age, hippocampus sparing and other OAR
sparing is outlined in Tables 1 and 2 for the
10 and 2 mm margin plans, respectively. Exam-
ination of the raw data demonstrated no differ-
ence in results between hippocampi as separate
structures versus as a single structure, thus the
table includes the results for the hippocampi as
a combined structure. An illustration of the
coplanar and non-coplanar plans hippocampus
sparing plans is shown in Figure 2. Composite
dosevolume histograms for the six patients
planned are presented in Figure 3.
Inspection of the results revealed that the
maximum hippocampus sparing was achieved
with the combination of the 2 mm PTV mar-
gin and a three non-coplanar arc plan, i.e.,
RA2_3, where the V6Gy and V18Gy were
<5% and 0%, respectively, and the average
mean dose was 3  0.3 Gy (Figure 2b and
Table 2). However, with a 2 mm PTV margin,
all techniques (coplanar or non-coplanar) con-
ferred significant hippocampus sparing. Com-
parisons of dose delivered to other OAR
(brain, brainstem, optic nerves) revealed differ-
ences between the five techniques; although
these differences were generally small and of a
magnitude that is unlikely to be clinically
important. In addition, no attempt was made
to minimise dose to non-hippocampus OAR
provided the tolerance thresholds were
respected. The non-coplanar techniques were
not associated with a meaningfully higher
integral dose or mean dose to brain compared
to coplanar techniques.
More pronounced differences between the
different techniques were seen with the use of
the larger, 10 mm PTV margins. In particular,
for the most stringent hippocampus parameter
(V6Gy), only the non-coplanar plans were able
to provide meaningful sparing with approxi-
mately 50% of the hippocampus volume main-
tained below 6 Gy. The PTV10 HT plans
Figure 1. A non-hippocampus sparing HT plan (left) compared to a maximally sparing HT plan (right). Significant hippocampus
(H) sparing is achieved but at the expense of slightly higher brainstem (B) dose and heterogeneity of dose in the PTV.
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provided the least hippocampus sparing and less
brain sparing (Table 1). Larger doses to the tis-
sue just above and below the target in HT plans
(see right hand panels in Figures 2a,b coronal
and sagittal views) are due to the helical delivery
with fixed fan beam width. This effect could be
eliminated with the implementation of a mov-
ing jaw.21,22 Comparison of other OAR doses
revealed less favourable dose metrics with the
larger PTV margin, and less advantage with
non-coplanar techniques compared to the
coplanar techniques.
With respect to the tumour coverage,
the introduction of hippocampus sparing
was achieved without compromising target
Table 1. Comparisons using a 10mm PTV margin (PTV10)
Organ/Structure Parameter HT10 RA10_1 RA10_2 RA10_3 p < 0.05
GTV Mean (Gy) 50.7  0.2 50.8  0.3 50.6  0.2 50.5  0.2 e
D1% (Gy) 51.4  0.5 51.6  0.3 51.1  0.3 51.1  0.2 e
D5% (Gy) 51.2  0.4 51.3  0.3 51.0  0.3 50.9  0.2 e
D95% (Gy) 50.3  0.1 50.3  0.4 50.3  0.2 50.2  0.2
D99% (Gy) 50.1  0.1 50.1  0.3 50.1  0.2 50.0  0.3
V95% (%) 100.0  0.0 100.0  0.0 100.0  0.0 100.0  0.0
PTV10 Mean (Gy) 50.7  0.2 51.0  0.2 50.8  0.2 50.8  0.2 a,e
D1% (Gy) 51.5  0.4 52.6  0.3 52.1  0.3 52.0  0.3 a,b,c,d,e
D5% (Gy) 51.2  0.3 52.1  0.3 51.7  0.2 51.7  0.2 a,b,c,e
D95% (Gy) 50.0  0.0 50.0  0.0 50.0  0.0 50.0  0.0
D99% (Gy) 48.6  1.4 49.3  0.3 49.2  0.3 49.2  0.3
V95% (%) 99.6  0.6 99.8  0.2 99.9  0.1 99.9  0.2
Brain Mean (Gy) 11.6  2.1 7.3  2.4 8.0  2.0 8.0  1.9 a,b,c,e
D5% (Gy) 37.0  6.4 30.9  8.2 26.2  9.3 26.5  9.4 a,b,c,d,e
D20% (Gy) 17.8  2.7 12.4  3.9 12.0  2.8 11.6  2.4 a,b,c
D50% (Gy) 9.0  1.8 2.5  2.7 5.4  1.4 5.5  1.3 a,b,c,d,e
V10Gy (%) 46.0  8.7 25.7  9.3 25.9  7.6 24.9  7.0 a,b,c
CI95% 1.6  0.3 1.4  0.2 1.4  0.3 1.4  0.2 b,c
EI (%) 37.4  25.9 32.8  21.6 29.5  23.1 29.6  22.0
ID 1.50  3.46 0.96  3.62 1.03  3.14 1.04  3.05 a,b,c,e
Brainstem Mean (Gy) 32.0  2.9 26.4  1.7 24.1  3.0 23.7  2.7 a,b,c,d,e
D1% (Gy) 50.7  0.5 50.8  0.5 50.1  0.8 50.5  0.7 b,d,f
D10% (Gy) 47.7  2.1 47.1  2.6 43.8  6.0 44.8  4.7 c,e
D50% (Gy) 32.1  3.3 28.5  3.1 21.9  3.0 22.5  2.8 b,c,d,e
Hippocampus Mean (Gy) 15.3  1.1 11.3  1.3 7.4  1.2 7.2  0.9 a,b,c,d,e
D1% (Gy) 25.2  2.7 21.0  3.5 20.1  5.7 19.6  5.1
D5% (Gy) 20.8  1.2 16.9  1.9 14.4  3.5 13.9  3.1 a,b,c,d,e
D20% (Gy) 17.4  0.6 13.5  1.4 9.7  1.7 9.3  1.3 a,b,c,d,e
D50% (Gy) 14.9  0.9 10.7  1.2 6.5  1.0 6.3  0.5 a,b,c,d,e
V6Gy (%) 100.0  0.0 98.1  3.0 55.7  12.2 54.4  7.8 b,c,d,e
V18Gy (%) 15.7  4.5 3.7  3.1 2.3  2.4 2.0  2.1 a,b,c,d,e
L Optic Nerve Mean (Gy) 26.6  6.8 25.5  9.2 19.7  9.3 19.1  8.9 b,c,d,e
D1% (Gy) 43.2  9.3 40.7  11.6 38.4  14.4 37.8  15.0
D10% (Gy) 38.5  12.6 37.0  14.3 34.4  16.7 33.6  17.1 d
D50% (Gy) 25.2  7.5 24.1  10.0 17.9  11.5 16.9  9.6 b,c,d,e
R Optic Nerve Mean (Gy) 27.4  5.5 25.8  7.6 17.7  7.6 17.5  6.6 b,c,d,e
D1% (Gy) 47.8  4.5 46.4  7.6 42.9  12.6 43.0  12.1
D10% (Gy) 42.6  9.9 40.2  12.1 36.3  16.4 36.0  16.2
D50% (Gy) 24.9  6.1 22.9  7.0 12.8  6.3 12.5  4.5 b,c,d,e
Lens D1% (Gy) 5.5  1.5 6.6  2.0 2.6  0.9 2.7  1.1 b,c,d,e
p < 0.05: comparisons significant at a level of 0.05 or less; CI95%: conformity index for 95% isodoses. EI%: percentage of brain receiving more than prescription
dose; ID: Integral dose (105 · Gy · cm3)
Comparisons: a: HT10 vs. RA10_1; b: HT10 vs. RA10_2; c: HT10 vs. RA10_3; d: RA10_1 vs. RA10_2; e: RA10_1 vs. RA10_3; f: RA10_2 vs. RA10_3; i.e., RA10_1 vs.
RA10_3 is RA plan with 10mm PTV, 1 co-planar arc compared to RA plan with 10mm PTV and 3 non-coplanar fields.
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coverage. D95 was greater than 50 Gy for all
techniques with both the 2 and 10 mm PTV
margins, and all GTV and PTV dose metrics
were similar. Dose homogeneity (D1  D99)
was excellent among all the techniques; con-
formity indices for the RA plans were margin-
ally better than for the HT plans, 1.31.4
versus 1.51.6, respectively (Tables 1 and 2).
DISCUSSION
Contouring of the hippocampi using CT-based
anatomical landmarks allowed these structures
to be designated as avoidance volumes in HT
and volumetric arc planning, with consequent
reduction in hippocampus dose. Barani et al.
have postulated the dose tolerance of the neural
Table 2. Comparisons using a 2mm PTV margin (PTV2)
Organ/Structure Parameter HT2 RA2_1 RA2_2 RA2_3 p < 0.05
GTV Mean (Gy) 51.4  0.1 50.9  0.3 50.6  0.3 50.7  0.4 a,b,c
D1% (Gy) 52.5  0.4 51.5  0.3 51.3  0.3 51.3  0.5 a,b,c
D5% (Gy) 52.2  0.4 51.3  0.3 51.1  0.3 51.1  0.5 a,b,c
D95% (Gy) 50.3  0.1 50.4  0.3 50.3  0.4 50.4  0.4
D99% (Gy) 49.8  0.1 50.2  0.2 50.1  0.4 50.3  0.4 a
V95% (%) 100.0  0.0 100.0  0.0 100.0  0.0 100.0  0.0
PTV2 Mean (Gy) 51.3  0.2 50.8  0.2 50.7  0.2 50.7  0.3 a,b,c
D1% (Gy) 52.6  0.4 51.8  0.4 51.6  0.2 51.6  0.4 a,b,c
D5% (Gy) 52.3  0.4 51.5  0.4 51.4  0.2 51.4  0.4 a,b,c
D95% (Gy) 50.0  0.0 50.0  0.0 50.0  0.0 50.0  0.0
D99% (Gy) 48.2  0.5 49.0  0.4 49.4  0.2 49.4  0.2 a,b,c
V95% (%) 99.5  0.4 99.9  0.1 100.0  0.0 100.0  0.0 a,b,c
Brain Mean (Gy) 5.9  1.7 4.1  1.7 4.5  1.4 4.3  1.4 a,b,c,f
D5% (Gy) 25.7  5.1 19.5  6.2 14.4  4.6 14.0  5.4 a,b,c,d,e
D20% (Gy) 9.7  3.7 6.3  3.0 7.5  1.8 6.6  1.6 a,c,f
D50% (Gy) 1.9  1.2 0.9  0.8 2.6  1.0 2.6  0.9 a,c,d,e
V10Gy (%) 19.4  6.1 12.7  5.5 11.5  6.1 9.1  4.8 a,b,c,e,f
CI95% 1.5  0.5 1.3  0.4 1.3  0.4 1.3  0.4 b,c
EI (%) 28.0  36.5 23.4  33.0 21.8  31.0 21.6  31.3
ID 7.76  2.56 5.36  2.54 5.912  2.167 5.66  2.19 a,b,c,f
Brainstem Mean (Gy) 19.0  5.0 15.6  2.2 14.1  1.8 12.9  1.8 a,b,c,e,f
D1% (Gy) 41.0  7.8 40.9  5.6 37.6  7.4 37.8  7.4 b,d,e,f
D10% (Gy) 31.8  6.9 31.3  3.1 24.8  3.8 24.5  4.3 b,c,d,e
D50% (Gy) 19.7  6.7 15.2  3.4 12.9  1.9 12.3  1.8 b,c,e,f
Hippocampus Mean (Gy) 4.1  0.5 4.2  0.9 3.0  0.4 3.0  0.3 b,c,d,e
D1% (Gy) 20.6  3.3 14.0  5.0 8.4  1.8 8.3  1.5 a,b,c,d,e
D5% (Gy) 13.6  3.8 9.6  2.9 5.9  1.5 5.9  1.1 a,b,c,d,e
D20% (Gy) 3.9  0.3 5.1  1.0 3.7  0.6 3.7  0.4 a,d,e
D50% (Gy) 2.8  0.2 3.4  0.6 2.6  0.3 2.6  0.2 a,d,e
V6Gy (%) 12.9  2.4 14.1  6.3 5.0  4.1 4.8  2.8 b,c,d,e
V18Gy (%) 2.7  1.9 0.5  0.8 0.0  0.0 0.0  0.0 a,b,c
L Optic Nerve Mean (Gy) 18.9  5.3 15.6  7.4 9.4  5.4 9.9  6.1 a,b,c,d,e
D1% (Gy) 36.2  15.8 32.7  17.9 28.7  19.9 28.8  19.4 b,c,d,e
D10% (Gy) 30.6  13.7 25.8  14.5 18.9  13.8 19.3  14.3 a,b,c,d,e
D50% (Gy) 16.6  3.7 13.6  6.1 6.8  3.2 7.6  4.2 b,c,d,e
R Optic Nerve Mean (Gy) 16.5  3.5 15.3  5.0 7.6  3.1 8.2  3.5 b,c,d,e
D1% (Gy) 36.0  13.6 35.1  14.1 28.2  18.0 28.0  17.1 b,c,d,e
D10% (Gy) 27.3  11.6 25.3  10.2 16.4  10.6 16.7  10.1 b,c,d,e
D50% (Gy) 14.4  4.9 13.2  4.3 5.1  1.5 5.9  2.1 b,c,d,e
Lens D1% (Gy) 5.7  0.8 9.0  1.0 3.8  1.0 3.8  0.7 a,b,c,d,e
p < 0.05: comparisons significant at a level of 0.05 or less; CI95%: Conformity index for 95% isodoses; EI% percentage of brain receiving more than prescription dose;
ID: Integral dose (105 · Gy · cm3).
Comparisons: a: HT2 vs. RA2_1; b: HT2 vs. RA2_2; c: HT2 vs. RA2_3; d: RA2_1 vs. RA2_2; e: RA2_1 vs. RA2_3; f: RA2_2 vs. RA2_3; i.e. RA2_1 vs. RA2_3 is RA plan
with 2mm PTV, 1 co-planar arc compared to RA plan with 2mm PTV and 3 non-coplanar fields.
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Figure 2. (a) Dose distributions in axial, coronal, and sagittal views for the radiation delivery plans with a 10 mm GTV to PTV
margin for (on left): HT, co-planar volumetric arc, (on right) non-coplanar 2 orthogonal volumetric arc, and non-coplanar 3 arc tech-
niques. Mean dose to the hippocampi are indicated below each technique. (b) Dose distributions in axial, coronal, and sagittal views
for the radiation delivery plans a 2 mm GTV to PTV margin for (on left): HT, co-planar volumetric arc, (on right) non-coplanar
2 orthogonal volumetric arc, and non-coplanar 3 arc techniques. Mean dose to the hippocampi are indicated below each technique.
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stem cells compartments, including the hip-
pocampus, to be in the range of 1020 Gy9,10
and this corresponds to clinical observations of
a threshold for neurocognitive side effects and
MRI changes when doses exceed 1820
Gy.19 Gutie´rrez et al. in comparison set objec-
tives of keeping the dose to the entire hip-
pocampi less than 6 Gy, recognising the
Figure 3. (a) Composite dosevolume histograms of the PTV and organs at risk for plans with a 10 mm GTV to PTV margin for
helical tomotherapy (HT10; blue solid), co-planar volumetric arc (RA_1; red dots), non-coplanar 2 arc (RA_2; green dash), and
non-coplanar 3 arc techniques (RA_3; blue dash). (b) Composite dosevolume histograms of the PTV and organs at risk for a
2 mm GTV to PTV margins for helical tomotherapy (HT10; blue solid), co-planar volumetric arc (RA_1; red dots), non-coplanar
2 arc (RA_2; green dash), and non-coplanar 3 arc techniques (RA_3; blue dash).
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radiosensitivity of stem cell populations.11 In
our planning study, the combination of a tight
PTV margin and intensity modulated arc deliv-
ery (via coplanar or non-coplanar techniques)
allowed a reduction of hippocampus dose to a
mean dose of 34 Gy, while maintaining
PTV coverage and respecting other OAR toler-
ance doses, meeting the most stringent dose
objectives above.11 Given the fact that our
hippocampal volumes were generous (due to
contouring on CT vs. MRI), sparing with
MRI defined hippocampal volumes (or ideally
Figure 3. (Continued)
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imaging defined stem cell sub-compartments)
could anticipated to be even more profound.
In comparison, a standard, coplanar three field
pituitary plan or non-hippocampus sparing
coplanar intensity modulated arc delivery might
be expected to deliver doses of 2025 Gy to
the hippocampi (Figure 1), in excess of the
doses postulated to result in stem cell loss and
neurocognitive changes.12,16,19
The coplanar nature of the skull base and hip-
pocampus creates challenges in sparing these
structures without increasing brainstem or eye
dose due to the limited numbers of in plane
‘‘corridors’’ to deliver dose to central tumours
while simultaneously limiting dose to the sur-
rounding OAR. This limitation applies to
both HT and co-planar IMRT delivery techni-
ques and has been noted by other authors.23 In
our comparisons, the use of tighter PTV mar-
gins was of greater importance than non-copla-
nar delivery or co-planar technique with respect
to sparing of both hippocampi and other OAR.
The CTV margin can be minimised through
improved GTV and CTV definition by accurate
multi-modality imaging and co-registration for
contouring, and the PTV margin can be mini-
mised through accurate localisation for treat-
ment using non-invasive stereotactic image
guidance techniques such as optical or on-board
CT guidance.5 In situations where the PTV is
in close proximity to multiple OAR due to lar-
ger margins or target anatomy, our comparisons
suggest non-coplanar arcs may confer an
advantage over co-planar delivery. Others
authors have reported improved results with
non-coplanar versus coplanar radiation delivery
for base of skull tumours.23 A potential disad-
vantage of non-coplanar arc delivery is the pos-
sibility of exit of arcs through structures such as
the lungs, thyroid and other soft tissues outside
of the calvarium (depending on the orientation
of the arcs). Thus a strategy of optimising
PTV margins combined with coplanar delivery
might be the most prudent if considering dose
reduction to extracranial structures.
Given the importance of planning margins,
improved delineation of target and OAR
volumes could also improve margin design to
facilitate OAR sparing. For instance, the pres-
ence of neuron progenitor cells in the human
hippocampus and subventricular zone has been
confirmed through in vivo imaging with 1H-
MRS.24 This finding suggests that in the future,
non-invasive delineation of stem cell popula-
tions might be incorporated into the planning
process for conformal avoidance, thus sparing
stem cells and allowing for regeneration and
repair of surrounding neural tissue. As a simpler
approach to spare the subventricular neural stem
cell zone along the lateral aspect of the lateral
ventricles without functional imaging techni-
ques, Barani et al. recommend designating an
avoidance area within a 5 mm lateral expansion
of the lateral ventricles to optimise neural stem
cell preservation during radiation delivery.9,10
The hippocampi are paired bilateral structures,
of which the left hippocampus is generally dom-
inant for memory in right-handed individuals.
Selective sparing of the dominant hippocampus
and associated neural stem cell region, or the
hippocampus contralateral to the tumour vol-
ume for more lateralised tumours, might also
facilitate neural stem cell-sparing radiation plans.
Ultimately, the efficacy of stem cell sparing
techniques needs to be confirmed through cor-
relation between dosimetry and relevant neuro-
cognitive outcomes in prospectively treated
patients. Future considerations for ongoing
research in this area could include a magnetic
resonancespectroscopy study of patients pre-
viously treated with radiation for CNS tumours.
Spectral changes in hippocampus could be
quantified and correlated with radiation dose
to hippocampus dose received. Prospective
functional imaging studies could evaluate the
degree of activity preserved with hippocampus
sparing radiotherapy techniques. Such morpho-
logic and spectroscopic changes have been
described for patients with neurodegenerative
disease such as Alzheimer’s2527 and may be a
complement to traditional neurocognitive test-
ing, particularly as a potential early biomarker
of injury.
CONCLUSIONS
Patients with base of brain tumours represent a
patient population with long-life expectancy
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after treatment for malignancy, and stand to
gain significant benefit from reducing late neu-
rocognitive sequelae of radiation treatments.
Hippocampus contouring and specification as
an avoidance structure in helical or volumetric
arc techniques can achieve significant reduction
in dose to the hippocampi. Our comparisons
suggest interventions to minimise GTV to
PTV margins will have a more profound influ-
ence on multiple OAR sparing than the choice
of intensity modulated arc delivery technique.
Prospective studies with larger numbers of
patients treated with a wider variety of base of
skull tumours and including neurocognitive
endpoints would help define the potential clin-
ical benefits of these hippocampal sparing tech-
niques.
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